Tags:BioTechDevelopmentDrugIndustryITLEDManagementMedTechSearchTechnology
Spin-off from the Pasteur Institute, DIACCURATE is a late preclinical stage biotechnology company which develops “sole-in-class” therapeutics in oncology and immunotherapy.
Location: France, Ile-de-France, Paris
Founded date: 2014

Investors 1

Mentions in press and media 2

DateTitleDescriptionCategoryAuthorSource
08.09.2021DIACCURATE...DGAP-News: DIACCURATE SAS / Ke...--marketscre...
12.01.2021DIACCURATE...BIOKINESIS absorption by DIACC...--marketscre...